If you’ve been researching alternatives to antidepressants, you’ve probably come across ketamine and esketamine. You might even be wondering: “Esketamine vs ketamine—are they the same thing?” Short answer: not exactly. While they’re closely related, the way they’re administered, monitored, and covered by insurance can be very different.
In this guide, we’ll break down the differences between ketamine infusions and Spravato (esketamine), explain what’s covered by insurance, how long each treatment lasts, how much they cost, and which option might be right for you.
Ketamine is a well-known anesthetic that has been used off-label for depression for over two decades. Esketamine, on the other hand, is a refined version of ketamine—essentially one “half” of the ketamine molecule—that was developed and FDA-approved under the brand name Spravato™ to treat treatment-resistant depression and major depressive disorder with suicidal thoughts.
At Axis Integrated Mental Health, we are proud to be Colorado’s top-certified Spravato clinic. Our providers have helped hundreds of patients begin their healing journey using FDA-approved esketamine treatments, fully covered by most insurance plans.
Ready to get started?
➡️ Take the quiz to see if you qualify.
Yes—Spravato (esketamine) is FDA-approved and covered by most major insurance plans, including Medicaid. Unlike traditional ketamine infusions, which are considered off-label and often not reimbursed, Spravato is widely accessible thanks to insurance coverage.
Without insurance, a course of Spravato treatment can cost several thousand dollars—but most patients don’t pay the full price. The Spravato With Me Savings Program can bring your out-of-pocket costs down dramatically—often as little as $10 per treatment if you qualify. Read our article for more information about how much Spravato costs.
Ketamine infusions, which are not FDA-approved for depression, are typically not covered by insurance. Patients often pay $350–$500 per infusion, and a full course can cost $3,000–$5,000 or more. You can read more about how much ketamine infusions cost in our deep dive article.
Feature |
Spravato (Esketamine) |
Ketamine Infusions |
FDA Approval |
✅ Yes (for depression) |
❌ No (off-label use only) |
Insurance Coverage |
✅ Most insurance plans, including Medicaid |
❌ Usually out-of-pocket |
Route of Administration |
Nasal spray in a clinic setting |
Intravenous infusion in a clinical setting |
Cost |
Often as little as $10 with savings program. $8,150 per year granted to commercially insured patients towards the cost of medication to cover deductibles and out-of-pocket expenses. |
$350–$600 per session |
Setting |
Supervised in a certified clinic |
Medical office or clinic |
Monitoring Requirements |
2 hours of observation per visit |
Varies; often 1–2 hours |
Can You Use at Home? |
❌ No—Spravato must be administered in-clinic |
❌ No—infusions require a monitored setting |
Duration of Effects |
1–2 weeks between maintenance doses after induction |
1 week or more, but varies by individual |
Success Rate |
~50-70% after 6–8 weeks for treatment-resistant depression |
~50-80% reported improvement, though varies widely |
Ease of Access |
Requires a certified Spravato treatment center |
Many clinics offer infusions, but fewer are regulated |
Want a deeper dive into how these compare? Read our full guide: https://www.axismh.com/post/which-is-better-ketamine-infusions-vs-spravato
Both treatments typically begin with a more intensive phase and then taper into maintenance.
No. Both Spravato and ketamine infusions must be administered under supervision. With Spravato, you’re monitored for 2 hours post-treatment in a certified clinic due to safety regulations. Ketamine also requires post-infusion observation due to potential dissociation or sedation. While other forms of ketamine (e.g. lozenges or compounded ketamine) are available for home use, we highly discourage patients from at-home ketamine for safety reasons.
Both treatments are considered highly effective for people with treatment-resistant depression, though individual response varies.
According to a recent study and previous research, there is no difference in efficacy between Ketamine infusions vs. Spravato. Side effects were also equal. In another study from Cambridge, published in The Journal of Clinical Psychiatry, it was noted that "Intravenous ketamine and intranasal esketamine showed similar response/remission in TRD patients but the number of treatments required to achieve response/remission was significantly lower with Ketamine infusions vs. Spravato."
If you're deciding between esketamine vs ketamine, consider the following:
At Axis Integrated Mental Health, we offer Spravato treatments in Denver County, Boulder County, and Adams and Jefferson Counties, and we’re here to walk you through every step—from insurance approvals to tracking your progress.
Take our Spravato qualification quiz to see if you are a good candidate for treatment.
Or book an appointment with a board-certified provider to get started on your recovery.